Otsuka’s Q1 Pharma Sales Climb 20.3% Buoyed by Global Products

May 15, 2023
Otsuka Holdings’ pharmaceutical revenue in January-March surged more than 20% over the same period of the previous year with major contributions from its four global brands including the long-acting antipsychotic agent Abilify Maintena (aripiprazole). In the first quarter of the...read more